J Korean Med Sci.  2016 Sep;31(9):1503-1504. 10.3346/jkms.2016.31.9.1503.

Letter to the Editor: Objective Assessment of Surgical Restaging after Concurrent Chemoradiation for Locally Advanced Pancreatic Cancer

• Karabicak

• KMID: 2468287
• DOI: http://doi.org/10.3346/jkms.2016.31.9.1503

Abstract

No abstract available.

MeSH Terms

*Chemoradiotherapy
Combined Modality Therapy
Humans
*Pancreatic Neoplasms

Reference

1. Paik WH, Lee SH, Kim YT, Park JM, Song BJ, Ryu JK. Objective assessment of surgical restaging after concurrent chemoradiation for locally advanced pancreatic cancer. J Korean Med Sci. 2015; 30:917–923.

2. Coté GA, Smith J, Sherman S, Kelly K. Technologies for imaging the normal and diseased pancreas. Gastroenterology. 2013; 144:1262–1271.e1.

3. Contreras CM, Stanelle EJ, Mansour J, Hinshaw JL, Rikkers LF, Rettammel R, Mahvi DM, Cho CS, Weber SM. Staging laparoscopy enhances the detection of occult metastases in patients with pancreatic adenocarcinoma. J Surg Oncol. 2009; 100:663–669.

4. Satoi S, Yanagimoto H, Toyokawa H, Inoue K, Wada K, Yamamoto T, Hirooka S, Yamaki S, Yui R, Mergental H, et al. Selective use of staging laparoscopy based on carbohydrate antigen 19-9 level and tumor size in patients with radiographically defined potentially or borderline resectable pancreatic cancer. Pancreas. 2011; 40:426–432.

5. Hashimoto D, Chikamoto A, Sakata K, Nakagawa S, Hayashi H, Ohmuraya M, Hirota M, Yoshida N, Beppu T, Baba H. Staging laparoscopy leads to rapid induction of chemotherapy for unresectable pancreatobiliary cancers. Asian J Endosc Surg. 2015; 8:59–62.

6. Hirabayashi K, Imoto A, Yamada M, Hadano A, Kato N, Miyajima Y, Ito H, Kawaguchi Y, Nakagohri T, Mine T, et al. Positive intraoperative peritoneal lavage cytology is a negative prognostic factor in pancreatic ductal adenocarcinoma: a retrospective single-center study. Front Oncol. 2015; 5:182.

7. Satoi S, Fujii T, Yanagimoto H, Motoi F, Kurata M, Takahara N, Yamada S, Yamamoto T, Mizuma M, Honda G, et al. Multicenter phase II study of intravenous and intraperitoneal paclitaxel with S-1 for pancreatic ductal adenocarcinoma patients with peritoneal metastasis. Ann Surg. Forthcoming 2016.